Logo-apb
Adv Pharm Bull. 2020;10(1): 114-118. doi: 10.15171/apb.2020.014
PMID: 32002369        PMCID: PMC6983982

Research Article

Evaluation of Amikacin Pharmacokinetics in Critically Ill Patients with Intra-abdominal Sepsis

Bita Shahrami 1 ORCID, Farhad Najmeddin 1 ORCID, Mohammad Reza Rouini 2 ORCID, Atabak Najafi 3 ORCID, Kourosh Sadeghi 1 ORCID, Shahideh Amini 1 ORCID, Seyedeh Sana Khezrnia 4 ORCID, Hamid Reza Sharifnia 3 ORCID, Mojtaba Mojtahedzadeh 1 * ORCID

Cited by CrossRef: 7


1- Sadeghi K, Shahrami B, Hosseini Fani F, Hamishehkar H, Mojtahedzadeh M. Detection of subclinical nephrotoxicity induced by aminoglycosides in critically ill elderly patients using trough levels and urinary neutrophil gelatinase-associated lipocalin. Eur J Hosp Pharm. 2022;29(e1):e63 [Crossref]
2- Ghaffari S, Hadi A, Najmeddin F, Shahrami B, Rouini M, Najafi A, Mojtahedzadeh M. Evaluation of amikacin dosing schedule in critically ill elderly patients with different stages of renal dysfunction. Eur J Hosp Pharm. 2022;29(e1):e67 [Crossref]
3- Telles J, Diegues M, Migotto K, de Souza Borges O, Reghini R, Gavazza B, Pinto L, Caruso P, e Silva I, Schmidt S, de Lima Moreira F. Failure to predict amikacin elimination in critically ill patients with cancer based on the estimated glomerular filtration rate: applying PBPK approach in a therapeutic drug monitoring study. Eur J Clin Pharmacol. 2023;79(7):1003 [Crossref]
4- Li S, Zhu S, Xie F. Population pharmacokinetic/pharmacodynamic evaluations of amikacin dosing in critically ill patients undergoing continuous venovenous hemodiafiltration. 2023;75(4):515 [Crossref]
5- Shahrami B, Najmeddin F, Ghaffari S, Najafi A, Rouini M, Mojtahedzadeh M, Tran Q. Area under the Curve-Based Dosing of Vancomycin in Critically Ill Patients Using 6-Hour Urine Creatinine Clearance Measurement. Critical Care Research and Practice. 2020;2020:1 [Crossref]
6- Shahrami B, Arabzadeh A, Najmeddin F, Sefidani Forough A, Najafi A, Rouini M, Mojtahedzadeh M. Can Intra-abdominal Pressure Predict the Pharmacokinetics of Aminoglycosides in Critically Ill Patients With Intra-abdominal Sepsis?. 2022;29(3):e376 [Crossref]
7- Gras-Martín L, Plaza-Diaz A, Zarate-Tamames B, Vera-Artazcoz P, Torres O, Bastida C, Soy D, Ruiz-Ramos J. Risk Factors Associated with Antibiotic Exposure Variability in Critically Ill Patients: A Systematic Review. Antibiotics. 2024;13(9):801 [Crossref]